| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| HumanPheno | Macrostomia | 8.07e-06 | 220 | 13 | 6 | HP:0000181 | |
| HumanPheno | Wide mouth | 8.07e-06 | 220 | 13 | 6 | HP:0000154 | |
| HumanPheno | Compulsive behaviors | 2.84e-05 | 158 | 13 | 5 | HP:0000722 | |
| HumanPheno | Autistic behavior | 6.57e-05 | 678 | 13 | 8 | HP:0000729 | |
| HumanPheno | Downslanted palpebral fissures | 8.21e-05 | 497 | 13 | 7 | HP:0000494 | |
| HumanPheno | Wide nasal bridge | 9.46e-05 | 508 | 13 | 7 | HP:0000431 | |
| HumanPheno | Thick nasal alae | 1.13e-04 | 39 | 13 | 3 | HP:0009928 | |
| HumanPheno | Functional abnormality of male internal genitalia | 1.19e-04 | 1269 | 13 | 10 | HP:0000025 | |
| HumanPheno | Slanting of the palpebral fissure | 1.24e-04 | 739 | 13 | 8 | HP:0200006 | |
| HumanPheno | Diagnostic behavioral phenotype | 1.34e-04 | 747 | 13 | 8 | HP:0025783 | |
| HumanPheno | Abnormal male reproductive system physiology | 1.64e-04 | 1314 | 13 | 10 | HP:0012874 | |
| HumanPheno | Anteverted nares | 1.75e-04 | 559 | 13 | 7 | HP:0000463 | |
| HumanPheno | Upturned nose | 1.75e-04 | 559 | 13 | 7 | HP:0000427 | |
| HumanPheno | Abnormal nostril morphology | 2.10e-04 | 575 | 13 | 7 | HP:0005288 | |
| HumanPheno | Syndactyly | 3.03e-04 | 417 | 13 | 6 | HP:0001159 | |
| HumanPheno | Abnormality of mouth size | 3.36e-04 | 425 | 13 | 6 | HP:0011337 | |
| HumanPheno | Delayed speech and language development | 3.58e-04 | 1123 | 13 | 9 | HP:0000750 | |
| HumanPheno | Abnormality of the male genitalia | 3.70e-04 | 1437 | 13 | 10 | HP:0010461 | |
| HumanPheno | Abnormal morphology of the nasal alae | 4.10e-04 | 639 | 13 | 7 | HP:0000429 | |
| HumanPheno | Abnormality of the palpebral fissures | 4.37e-04 | 880 | 13 | 8 | HP:0008050 | |
| HumanPheno | Azoospermia | 4.54e-04 | 1157 | 13 | 9 | HP:0000027 | |
| HumanPheno | Language impairment | 5.25e-04 | 1178 | 13 | 9 | HP:0002463 | |
| HumanPheno | Abnormality of upper lip vermillion | 5.44e-04 | 464 | 13 | 6 | HP:0011339 | |
| HumanPheno | Abnormal spermatogenesis | 5.69e-04 | 1190 | 13 | 9 | HP:0008669 | |
| HumanPheno | Abnormal external nose morphology | 5.81e-04 | 916 | 13 | 8 | HP:0010938 | |
| HumanPheno | Constipation | 5.97e-04 | 472 | 13 | 6 | HP:0002019 | |
| HumanPheno | Delayed ability to walk | 6.33e-04 | 304 | 13 | 5 | HP:0031936 | |
| HumanPheno | Abnormal male internal genitalia morphology | 8.04e-04 | 1243 | 13 | 9 | HP:0000022 | |
| Domain | SOXp | 3.40e-05 | 5 | 35 | 2 | PF12336 | |
| Domain | SOX_fam | 3.40e-05 | 5 | 35 | 2 | IPR022097 | |
| Domain | SET | 2.67e-03 | 41 | 35 | 2 | PF00856 | |
| Domain | SET | 3.35e-03 | 46 | 35 | 2 | SM00317 | |
| Domain | SET_dom | 3.95e-03 | 50 | 35 | 2 | IPR001214 | |
| Domain | SET | 3.95e-03 | 50 | 35 | 2 | PS50280 | |
| Domain | HMG_box | 4.43e-03 | 53 | 35 | 2 | PF00505 | |
| Domain | HMG_BOX_2 | 4.59e-03 | 54 | 35 | 2 | PS50118 | |
| Domain | HMG | 4.59e-03 | 54 | 35 | 2 | SM00398 | |
| Domain | - | 4.76e-03 | 55 | 35 | 2 | 1.10.30.10 | |
| Domain | HMG_box_dom | 6.59e-03 | 65 | 35 | 2 | IPR009071 | |
| Pubmed | 3.26e-08 | 7 | 35 | 3 | 18559478 | ||
| Pubmed | USF1 recruits histone modification complexes and is critical for maintenance of a chromatin barrier. | 7.54e-07 | 18 | 35 | 3 | 17846119 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 8111369 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 17346996 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 23904439 | ||
| Pubmed | Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation. | 9.82e-06 | 5 | 35 | 2 | 26436530 | |
| Pubmed | 2.06e-05 | 7 | 35 | 2 | 20407207 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 2.24e-05 | 341 | 35 | 5 | 32971831 | |
| Pubmed | Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes. | 2.28e-05 | 165 | 35 | 4 | 16107646 | |
| Pubmed | A conserved family of genes related to the testis determining gene, SRY. | 2.74e-05 | 8 | 35 | 2 | 1614875 | |
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 27806296 | ||
| Pubmed | 2.77e-05 | 58 | 35 | 3 | 16782087 | ||
| Pubmed | 4.40e-05 | 10 | 35 | 2 | 24841128 | ||
| Pubmed | 5.21e-05 | 407 | 35 | 5 | 12693553 | ||
| Pubmed | 5.38e-05 | 11 | 35 | 2 | 24349473 | ||
| Pubmed | 6.45e-05 | 12 | 35 | 2 | 27246266 | ||
| Pubmed | 7.62e-05 | 13 | 35 | 2 | 16510874 | ||
| Pubmed | SOX2-LIN28/let-7 pathway regulates proliferation and neurogenesis in neural precursors. | 7.62e-05 | 13 | 35 | 2 | 23884650 | |
| Pubmed | A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2. | 7.62e-05 | 13 | 35 | 2 | 8625802 | |
| Pubmed | 7.62e-05 | 13 | 35 | 2 | 12194848 | ||
| Pubmed | 8.89e-05 | 14 | 35 | 2 | 31712124 | ||
| Pubmed | 1.02e-04 | 15 | 35 | 2 | 16510875 | ||
| Pubmed | The REV7 subunit of DNA polymerase ζ is essential for primordial germ cell maintenance in the mouse. | 1.17e-04 | 16 | 35 | 2 | 23463509 | |
| Pubmed | 1.17e-04 | 16 | 35 | 2 | 24257626 | ||
| Pubmed | 1.17e-04 | 16 | 35 | 2 | 17699610 | ||
| Pubmed | 1.17e-04 | 16 | 35 | 2 | 10932191 | ||
| Pubmed | 1.17e-04 | 16 | 35 | 2 | 22115758 | ||
| Pubmed | 1.17e-04 | 16 | 35 | 2 | 24487434 | ||
| Pubmed | Chromatin boundaries require functional collaboration between the hSET1 and NURF complexes. | 1.33e-04 | 17 | 35 | 2 | 21653943 | |
| Pubmed | Spatio-temporal expression of Sox genes in murine palatogenesis. | 1.33e-04 | 17 | 35 | 2 | 27241892 | |
| Pubmed | 1.41e-04 | 808 | 35 | 6 | 20412781 | ||
| Pubmed | 1.49e-04 | 18 | 35 | 2 | 26864488 | ||
| Pubmed | A multistate stem cell dynamics maintains homeostasis in mouse spermatogenesis. | 1.66e-04 | 19 | 35 | 2 | 34686326 | |
| Pubmed | 1.66e-04 | 19 | 35 | 2 | 37516749 | ||
| Pubmed | Proteolysis of methylated SOX2 protein is regulated by L3MBTL3 and CRL4DCAF5 ubiquitin ligase. | 1.66e-04 | 19 | 35 | 2 | 30442713 | |
| Pubmed | 2.11e-04 | 549 | 35 | 5 | 38280479 | ||
| Pubmed | 2.24e-04 | 22 | 35 | 2 | 17084361 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 2.65e-04 | 908 | 35 | 6 | 19274049 | |
| Pubmed | 3.15e-04 | 26 | 35 | 2 | 33238123 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 3.34e-04 | 134 | 35 | 3 | 25452129 | |
| Pubmed | 3.40e-04 | 27 | 35 | 2 | 19208226 | ||
| Pubmed | 3.66e-04 | 28 | 35 | 2 | 19352218 | ||
| Pubmed | Sohlh2 affects differentiation of KIT positive oocytes and spermatogonia. | 3.66e-04 | 28 | 35 | 2 | 19014927 | |
| Pubmed | 4.49e-04 | 31 | 35 | 2 | 19723505 | ||
| Pubmed | Microarray analysis of the Df1 mouse model of the 22q11 deletion syndrome. | 4.49e-04 | 31 | 35 | 2 | 15778864 | |
| Pubmed | Specification of dopaminergic subsets involves interplay of En1 and Pitx3. | 4.49e-04 | 31 | 35 | 2 | 23863478 | |
| Pubmed | 4.77e-04 | 1429 | 35 | 7 | 35140242 | ||
| Pubmed | 5.31e-04 | 157 | 35 | 3 | 30186101 | ||
| Pubmed | 6.07e-04 | 36 | 35 | 2 | 23497137 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 6.43e-04 | 394 | 35 | 4 | 27248496 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 6.70e-04 | 1082 | 35 | 6 | 38697112 | |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 7.49e-04 | 40 | 35 | 2 | 34585037 | |
| Pubmed | 8.26e-04 | 42 | 35 | 2 | 35705031 | ||
| Pubmed | 8.26e-04 | 42 | 35 | 2 | 29438518 | ||
| Pubmed | 8.66e-04 | 43 | 35 | 2 | 36950384 | ||
| Pubmed | 9.48e-04 | 45 | 35 | 2 | 17687036 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 9.70e-04 | 440 | 35 | 4 | 34244565 | |
| Pubmed | 9.90e-04 | 46 | 35 | 2 | 20301533 | ||
| Pubmed | 9.95e-04 | 195 | 35 | 3 | 19454010 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q12 | 1.17e-03 | 66 | 35 | 2 | chr5q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q22 | 4.59e-03 | 132 | 35 | 2 | chr15q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q25 | 6.98e-03 | 164 | 35 | 2 | chr6q25 | |
| GeneFamily | SRY-boxes | 3.09e-04 | 19 | 25 | 2 | 757 | |
| Coexpression | GSE7852_TREG_VS_TCONV_THYMUS_UP | 6.63e-06 | 200 | 35 | 5 | M5730 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | 1.03e-05 | 584 | 35 | 7 | M39068 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | NR4A2 FBXO11 SMARCA5 THEMIS DPP8 KIT BHLHE40 ERBIN GZMB PRDM1 | 1.72e-05 | 1492 | 35 | 10 | M40023 |
| Coexpression | GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN | 1.27e-04 | 194 | 35 | 4 | M4683 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_MAC_UP | 1.35e-04 | 197 | 35 | 4 | M5401 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN | 1.43e-04 | 200 | 35 | 4 | M3610 | |
| Coexpression | GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_DN | 1.43e-04 | 200 | 35 | 4 | M5828 | |
| Coexpression | GSE7852_LN_VS_FAT_TCONV_DN | 1.43e-04 | 200 | 35 | 4 | M5748 | |
| Coexpression | GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN | 1.43e-04 | 200 | 35 | 4 | M4889 | |
| Coexpression | GSE7460_TCONV_VS_TREG_THYMUS_DN | 1.43e-04 | 200 | 35 | 4 | M5676 | |
| Coexpression | KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_DN | 1.43e-04 | 200 | 35 | 4 | M3017 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | 2.04e-04 | 411 | 35 | 5 | M1351 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | 2.16e-04 | 416 | 35 | 5 | MM1002 | |
| CoexpressionAtlas | alpha beta T cells, T.8.TI.B16, 4- 8+ TCR+ 45+, B16 Melanoma Tumor, avg-2 | 1.23e-07 | 75 | 34 | 5 | GSM605773_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_500 | 3.45e-05 | 116 | 34 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5-.IEL, CD8a+ CD8b- TCRgd+ Vg5- CD44lo, Small Intestine, avg-3 | 3.97e-05 | 405 | 34 | 6 | GSM605811_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5+.IEL, CD8a+ CD8b- TCRd+ Vg5+ CD44lo, Small Intestine, avg-3 | 4.55e-05 | 415 | 34 | 6 | GSM605805_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 6.50e-05 | 893 | 34 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 6.93e-05 | 8 | 34 | 2 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.31e-05 | 276 | 34 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000_k3 | |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.10e-04 | 1245 | 34 | 9 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#1_top-relative-expression-ranked_500 | 1.11e-04 | 10 | 34 | 2 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k1_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.21e-04 | 307 | 34 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k4 | |
| CoexpressionAtlas | alpha beta T cells, T.4.Sp.B16, 4+ 8- TCR+ 45+, B16 Melanoma Spleen, avg-2 | 1.91e-04 | 70 | 34 | 3 | GSM605761_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5-.IEL, CD8a+ CD8b- TCRgd+ Vg5- CD44lo, Small Intestine, avg-3 | 1.99e-04 | 71 | 34 | 3 | GSM605811_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_200 | 2.02e-04 | 183 | 34 | 4 | gudmap_dev gonad_e11.5_F_GonMes_Sma_200 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5+.act.IEL, CD8a+ CD8b- TCRd+ Vg5+ CD44hi, Small Intestine, avg-3 | 2.16e-04 | 73 | 34 | 3 | GSM605802_100 | |
| CoexpressionAtlas | NK cells, NK.H+.MCMV7.Sp, NK1.1+ TCRb- Ly49H+, Spleen, avg-3 | 2.34e-04 | 75 | 34 | 3 | GSM538303_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5+.IEL, CD8a+ CD8b- TCRd+ Vg5+ CD44lo, Small Intestine, avg-3 | 2.43e-04 | 76 | 34 | 3 | GSM605805_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8.TI.B16, 4- 8+ TCR+ 45+, B16 Melanoma Tumor, avg-2 | 2.50e-04 | 359 | 34 | 5 | GSM605773_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#3_top-relative-expression-ranked_200 | 2.58e-04 | 15 | 34 | 2 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k3_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | 2.84e-04 | 827 | 34 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 | |
| CoexpressionAtlas | cerebral cortex | 3.09e-04 | 1428 | 34 | 9 | cerebral cortex | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 3.45e-04 | 385 | 34 | 5 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5-.act.IEL, CD8a+ CD8b- TCRd+ Vg5- CD44hi, Small Intestine, avg-3 | 4.20e-04 | 402 | 34 | 5 | GSM605808_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_100 | 4.27e-04 | 92 | 34 | 3 | gudmap_dev gonad_e11.5_F_GonMes_Sma_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_100 | 4.27e-04 | 92 | 34 | 3 | gudmap_dev gonad_e11.5_M_GonMes_Sma_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5+.act.IEL, CD8a+ CD8b- TCRd+ Vg5+ CD44hi, Small Intestine, avg-3 | 4.59e-04 | 410 | 34 | 5 | GSM605802_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#2_top-relative-expression-ranked_500 | 5.13e-04 | 21 | 34 | 2 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 5.45e-04 | 100 | 34 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_500 | 5.83e-04 | 432 | 34 | 5 | gudmap_dev gonad_e11.5_M_GonMes_Sma_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_500 | 6.07e-04 | 436 | 34 | 5 | gudmap_dev gonad_e11.5_F_GonMes_Sma_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_ReproVasc_Flk_k-means-cluster#1_top-relative-expression-ranked_500 | 6.72e-04 | 24 | 34 | 2 | gudmap_dev gonad_e11.5_M_ReproVasc_Flk_k1_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_100 | 6.72e-04 | 24 | 34 | 2 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k2_100 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | 7.26e-04 | 967 | 34 | 7 | PCBC_ratio_ECTO_vs_MESO-5_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_200 | 9.16e-04 | 28 | 34 | 2 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k1_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_100 | 9.83e-04 | 29 | 34 | 2 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k4_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 1.05e-03 | 30 | 34 | 2 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k4_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 1.05e-03 | 30 | 34 | 2 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_200 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-09 | 188 | 35 | 6 | 7471c194276161422326647f09022e94f3d1640c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-09 | 188 | 35 | 6 | 053c251d3ddbeb866f34565aefca4535517b4387 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.93e-07 | 192 | 35 | 5 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | ILEUM-inflamed-(6)_ILC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.14e-07 | 194 | 35 | 5 | 4d51d49366c34ff1241770b4acc0167a43b3155a | |
| ToppCell | BAL-Control-cDC_5|Control / Compartment, Disease Groups and Clusters | 4.46e-07 | 197 | 35 | 5 | 8a3fe59be3ed1f0254cc8c60b99c840193370efb | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.81e-07 | 200 | 35 | 5 | 913487e065dd580c9cbcbb3c3fc76a8d446f8856 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-CD4+_CTL|Bac-SEP / Disease, condition lineage and cell class | 4.81e-07 | 200 | 35 | 5 | 78cce90288ee7224067f7b87c99c54737bed466d | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.15e-07 | 89 | 35 | 4 | d8832dbe69d3490ceaa05ccc99d7c81707803925 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.01e-06 | 145 | 35 | 4 | 78f5f4b96420c7f391e4d32a9ed151ed95fad90b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.20e-06 | 153 | 35 | 4 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.53e-06 | 155 | 35 | 4 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.53e-06 | 155 | 35 | 4 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.70e-06 | 156 | 35 | 4 | 029ba0832ee9c4a2c85620e4df2260e02d86b45c | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.70e-06 | 156 | 35 | 4 | 5df19a235843829f5a1a90ca21b0964ef8b4e115 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-06 | 157 | 35 | 4 | a84377028c661f8f3ecae0f6082abdd859faf0c8 | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-06 | 164 | 35 | 4 | ab9c17f86b98e1a4d5db1bd3086edab1320ebda8 | |
| ToppCell | Mild-Lymphoid-NK-CD8_T|Mild / Condition, Lineage, Cell class and cell subclass | 8.36e-06 | 165 | 35 | 4 | 9b0b037383e3e7cf7cfbc65b8d4c4721be3210f8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.97e-06 | 168 | 35 | 4 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.40e-06 | 170 | 35 | 4 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_Tfh|normal_Lung / Location, Cell class and cell subclass | 1.01e-05 | 173 | 35 | 4 | e8ead6c51c41dbd43c717ba9d1a7a0ab39c79330 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-05 | 173 | 35 | 4 | af85fb9f6e26a044ca4d23e5872039b1a7b73b1b | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 1.03e-05 | 174 | 35 | 4 | e324320b52c904496e26fcecfa179b3431729ec0 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 176 | 35 | 4 | e2b4be7d4f31a78d7862c0fd629dd9cc84589193 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 176 | 35 | 4 | 299075e65ca86564e1c0b06058bd4371a60a3bcd | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 177 | 35 | 4 | 0d894a14ddbb2734557743e9efdb89cee5c26769 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 177 | 35 | 4 | 6d86b2f97426b552dff5ce6ddf0ead1285ed618e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 177 | 35 | 4 | b75f519d72611b293d9684f7dcfb1b70fbf54a90 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-05 | 177 | 35 | 4 | 3a150dcaefa342d49968b42c7cdb1fbb633adcd0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 177 | 35 | 4 | 1cb78133ac09ea3a3f5b5de07151033998406512 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.10e-05 | 177 | 35 | 4 | c9e5820ff0bc7ad1adcfb2651713fdfc58bced56 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 177 | 35 | 4 | d8b1bbc224d062a57a6ad40b4b2af5d6e0fe63b3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-05 | 178 | 35 | 4 | f332c7a96844abecf05ca057480fbea9296688a2 | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 178 | 35 | 4 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-05 | 179 | 35 | 4 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-05 | 179 | 35 | 4 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | mild_COVID-19-NK_CD56bright|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.18e-05 | 180 | 35 | 4 | d8b418edd807a51c0b5f4018b8b478dcc65892a7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-05 | 180 | 35 | 4 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-05 | 181 | 35 | 4 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-05 | 182 | 35 | 4 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | Healthy_donor-MAIT|Healthy_donor / disease group, cell group and cell class (v2) | 1.23e-05 | 182 | 35 | 4 | ac7c83464487ecde3df6804a99551307bd768f21 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-05 | 182 | 35 | 4 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-05 | 182 | 35 | 4 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-05 | 182 | 35 | 4 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | mild_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 1.26e-05 | 183 | 35 | 4 | 9a4899afac0f91203209392c5f67b3d0aa356b86 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-05 | 183 | 35 | 4 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_Erythro-Mega-Erythrocytic_early|bone_marrow / Manually curated celltypes from each tissue | 1.26e-05 | 183 | 35 | 4 | d43ba3fbbd9132125fa2b7ea0891a2c577974f14 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-05 | 183 | 35 | 4 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 184 | 35 | 4 | f9365feed31e48f3382588bab077f99c5a3f5b04 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-05 | 184 | 35 | 4 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-05 | 184 | 35 | 4 | ae0a77e3e520a246b17776bb19503519636b02ee | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 184 | 35 | 4 | 290b8ef0bc4b7b99a2b35b96a756699d3f233b96 | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 184 | 35 | 4 | 43313b0b4e4d4b18dd67ac0c525d7aa4db493f71 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-05 | 185 | 35 | 4 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-05 | 185 | 35 | 4 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-05 | 185 | 35 | 4 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-05 | 185 | 35 | 4 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-05 | 185 | 35 | 4 | bdfa8c284bbc5e85c806327fbb7778cf16242a38 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-05 | 185 | 35 | 4 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-05 | 185 | 35 | 4 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.34e-05 | 186 | 35 | 4 | fc0b488c201a32d829047b58460297df2818b45d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-05 | 186 | 35 | 4 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-05 | 186 | 35 | 4 | 6f88b68735d0f7c9904eb8413e6007910d556185 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-05 | 186 | 35 | 4 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-05 | 187 | 35 | 4 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | ILEUM-inflamed-(1)_CD8_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.37e-05 | 187 | 35 | 4 | a77d7ae44f47410bd92fb3aa0f44dce891752b63 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.37e-05 | 187 | 35 | 4 | 6981b856187a2e689260ecb7d0a1193a374ee9b9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 188 | 35 | 4 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 188 | 35 | 4 | 433a25fe52914e07e7ba695881f9bcca2d9467ff | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 188 | 35 | 4 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 188 | 35 | 4 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 188 | 35 | 4 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like|bone_marrow / Manually curated celltypes from each tissue | 1.43e-05 | 189 | 35 | 4 | ac2995e599f3d1813218479dc515b1d612c0ef8b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-05 | 190 | 35 | 4 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | ILEUM|World / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.46e-05 | 190 | 35 | 4 | 4395dbd18c14d491f5066a2ddac438a16b1fd7c3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-05 | 190 | 35 | 4 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_CD8+_T|metastatic_Brain / Location, Cell class and cell subclass | 1.49e-05 | 191 | 35 | 4 | b98367fdb56ccb335d61035e69cd43c61a7fa816 | |
| ToppCell | (3)_MNP-(3)_DC_2|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.49e-05 | 191 | 35 | 4 | 3ff163484af8c12ef4eef87246cf044257fd2547 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.49e-05 | 191 | 35 | 4 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 191 | 35 | 4 | ece87127f85939e61b1048d968ed96f0e87c3a79 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 191 | 35 | 4 | 478e8341ee03b05501e2233e02cef5f97492c95d | |
| ToppCell | ILEUM-non-inflamed-(1)_CD8_Trm|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.52e-05 | 192 | 35 | 4 | a9f89043c97cd2b0ba165e69ee5681094410af37 | |
| ToppCell | ILEUM-non-inflamed-(1)_Cytotoxic_CD8_Trm|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.52e-05 | 192 | 35 | 4 | cc9287803cd979e4b81f0649527f1b3bf54d0b83 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-05 | 192 | 35 | 4 | 342842378c20267c5044bdd622515e8b9f895623 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-05 | 192 | 35 | 4 | bd3fa6c8fcb618db64d11f25cabaf08608957c35 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 193 | 35 | 4 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 193 | 35 | 4 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.55e-05 | 193 | 35 | 4 | 704378de39e1b6f108ab5b0ecbd594d414ec8ae4 | |
| ToppCell | lymphoid-NK_cell-NK_cell|World / Lineage, cell class and subclass | 1.58e-05 | 194 | 35 | 4 | 7f5adc18e632109694446b8eb1543cbae62dccbe | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.58e-05 | 194 | 35 | 4 | 36f8ae4f2b3bf802f6ff0e9fc79e7f170f96ae8b | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.58e-05 | 194 | 35 | 4 | a4523adbbd25c314809eed3414d66a5b323446e5 | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.58e-05 | 194 | 35 | 4 | 125bf2909cf89133693bc7b865ca08955cf67a2e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.58e-05 | 194 | 35 | 4 | 0fdf4d7d42d8f1f47eade2fb89ff35b188b9b51f | |
| ToppCell | lymphoid-NK_cell|World / Lineage, cell class and subclass | 1.58e-05 | 194 | 35 | 4 | 4bf5a140be8691e4ec99d7ee15588fd48acd6fb5 | |
| ToppCell | T_cells-CD56_dim_CD16+_NK_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.58e-05 | 194 | 35 | 4 | 335c6c2f3f319d4f19eace62f8826a0f40c130f6 | |
| ToppCell | 356C|World / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-05 | 195 | 35 | 4 | b19609f519188cf27859cbdc014e65fc38e24391 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.61e-05 | 195 | 35 | 4 | 98ca9f3aa36211dde1e6f7f3817b9418c95e583e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.65e-05 | 196 | 35 | 4 | bc4628d959d76c16981ac3b943f7c3fbbba49391 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.65e-05 | 196 | 35 | 4 | c100967851f037b3522130a9e2a4175ad593ecbc | |
| ToppCell | lymphoid-NK_cell|lymphoid / Lineage, cell class and subclass | 1.65e-05 | 196 | 35 | 4 | 0c7fb03ef782256f61624afc5c1bfaed9f1005fb | |
| ToppCell | lymphoid-NK_cell-NK_cell|lymphoid / Lineage, cell class and subclass | 1.65e-05 | 196 | 35 | 4 | 5e6238fe131e349013c60a73c99f84a6be7955ef | |
| Disease | Schizophrenia | 5.57e-05 | 883 | 34 | 7 | C0036341 | |
| Disease | schizophrenia (implicated_via_orthology) | 6.66e-05 | 68 | 34 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 2.25e-04 | 261 | 34 | 4 | C0004352 | |
| Disease | Epilepsy | 2.70e-04 | 109 | 34 | 3 | C0014544 | |
| Disease | beta-aminoisobutyric acid measurement | 3.50e-04 | 24 | 34 | 2 | EFO_0010464 | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 3.58e-04 | 295 | 34 | 4 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | Cutaneous Melanoma | 1.03e-03 | 41 | 34 | 2 | C0151779 | |
| Disease | Crohn's disease | 1.60e-03 | 441 | 34 | 4 | EFO_0000384 | |
| Disease | Intellectual Disability | 1.68e-03 | 447 | 34 | 4 | C3714756 | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.84e-03 | 55 | 34 | 2 | C0079744 | |
| Disease | Bipolar Disorder | 2.13e-03 | 477 | 34 | 4 | C0005586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SYREFHSAGRTPPMM | 1106 | Q96RT1 | |
| PGMYPAHMYQVYKSR | 26 | O14503 | |
| EAKPHSRPYMAYLMI | 26 | P10144 | |
| NYKRHMDGMYGPPAK | 1441 | Q8NFD5 | |
| IYKMYGSEMLHKRDP | 381 | Q96EP9 | |
| SYVEMKSPVHMGSPY | 961 | A6BM72 | |
| RRVLPPSAHGMMDDY | 116 | Q8N8D7 | |
| GFRMLSPEHAPAEMY | 886 | P10721 | |
| ESGDFLYRMRDYMPP | 301 | Q6ZQW0 | |
| LYRMRDYMPPSHKAF | 306 | Q6ZQW0 | |
| YARVAMAMGSHPRYR | 691 | O14782 | |
| CFPLHYPIRMSKRMY | 126 | Q8NG80 | |
| PEMHEYMRRYNVPAT | 811 | Q8TCU5 | |
| MKRYTAEDMYRPHPG | 201 | Q9UF02 | |
| SPSLPDKYRHAREMM | 1766 | Q8IZD9 | |
| YTRPMMHPEPGKFYQ | 206 | Q86XK2 | |
| PSIHRYMYPEMKITH | 216 | A4D1U4 | |
| ADTRKYHGYMMAKAP | 66 | Q6V1X1 | |
| MYRGKKRHEMPPHIY | 141 | P35580 | |
| EEMMPHSGSVYYKPS | 111 | P43354 | |
| RAVHMKEYPDYKYRP | 196 | P41225 | |
| AMHMKEHPDYKYRPR | 66 | Q9Y651 | |
| SEYPPYMMKRRDPAR | 101 | A1L4K1 | |
| ERLHYPYPGELTMMN | 206 | O75626 | |
| GAYSREAYHLPMPMA | 741 | O15047 | |
| YMMRRYESSASHPPP | 541 | Q8N1K5 | |
| PDEEPMHYGNIMYDR | 181 | Q86UC2 | |
| MSYAPFRDVRGPSMH | 16 | Q96PV0 | |
| YMEHRGYPMRAYKLA | 1036 | Q9HCJ5 | |
| MEKGRHMEYECPYLV | 306 | Q9NYA1 | |
| YMKHYRNIPGPHMVL | 221 | O60264 | |
| NYFKMSKRMYPHRPV | 201 | Q8IWU6 | |
| MPKPTHYYIKIARFM | 3486 | Q9Y4A5 | |
| RDKKGMDRGMYPTYF | 271 | P50607 | |
| MEFYMRTFRHMRPEP | 311 | Q8WTX9 | |
| YMKAEPPIPHYAAMG | 206 | Q9Y2G1 |